Logo

circulating miRNA

MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations

The Singapore-based biotech company will evaluate its miRNA biomarker assay for early detection of pulmonary hypertension as part of the SPHERE study.

European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer
Premium

The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.

DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development

The two grants awarded will support DiamiR's development of microRNA diagnostics for mild cognitive impairment, Alzheimer's disease, and Rett syndrome.

MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval
Premium

The firm recently published a study describing three assays for prostate cancer and reporting their sensitivity and specificity in case-control cohort.

Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer

A retrospective cohort study uncovered microRNA signatures that could tell lung cancer patients apart from others, including patients with other, non-tumor lung conditions.

Mar 28, 2019

MiR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer
Premium

Dec 6, 2018

Cancer Early Detection Firm Ark Launches With $40M Series A Investment

Sep 19, 2018

New Technique Allows Sequencing of Short RNAs From Dried Blood Spots, Other Small Samples
Premium

Jul 20, 2018

MiR Scientific Prepares Launch of First Clinical Cancer Test, Buoyed by New Data
Premium

Apr 10, 2018

Quadrant Biosciences Licenses SUNY, Penn State Epigenetic Biomarkers for Neuro Diseases

Nov 14, 2017

Dana-Farber Team Developing MicroRNA Liquid Biopsy to Diagnose Ovarian Cancer
Premium

Mar 10, 2017

Chinese Startup HeliTec Launches Large Liquid Biopsy Study

Nov 11, 2016

Circulating Maternal MicroRNAs Distinguish Infants Affected by Fetal Alcohol Syndrome

Sep 6, 2016

Prostate Cancer Grades Can Be Distinguished Using MicroRNA Signature, Study Finds

Mar 9, 2016

Startup Miroculus Shares Vision for Rapid, Inexpensive miRNA Diagnostics at Tri-Con
Premium

Dec 31, 2015

Early Data Encouraging for Development of Blood-Based MicroRNA Test for Germ Cell Cancers
Premium

Nov 6, 2015

HTG Updates NGS Assay Pipeline; Academic Partners Working on microRNA-Based Ovarian Cancer Subtyping

Aug 28, 2015

Moffitt Team Uses Nanostring Tech to ID MiRNA Signature for Early Pancreatic Cancer Detection
Premium

Jul 17, 2015

With NCI Funding, Baylor Team Developing microRNA-Based Colorectal Cancer Screen
Premium

May 6, 2015

With NCI Grant, Librede Looks to Develop Nanopore-Based microRNA Diagnostic
Premium

Feb 27, 2014

Singapore's MiRxes Spins Out from A*Star with Novel qPCR Assay Platform for microRNA Analysis
Premium

Feb 27, 2014

Q&A: UMich's Muneesh Tewari on miRNAs as Cancer Biomarkers, ddPCR as Detection Method
Premium

May 10, 2012

Australian Team Finds Blood miRNA with Potential for Early Diagnosis of Malignant Mesothelioma
Premium

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.